Navigation Links
LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
Date:9/8/2008

LegalView recently reported on the risk of bone fractures among patients using proton pump inhibitor (PPI) drugs. The drugs are used to treat and reduce gastric acid within the stomach as well as other stomach/intestinal issues including ulcers, gastroesophageal reflux disease (GERD), dyspepsia, some forms of stomach infections and Zollinger-Ellison Syndrome.

Denver, CO (PRWEB) September 8, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, recently alerted patients taking http://proton-pump-inhibitors-ppi.legalview.com [proton pump inhibitor __title__ Proton Pump Inhibitor Risks] (PPI) drugs of the potential for serious bone fracture risks associated with taking the medication. A study published in a recent issue of the Canadian Medical Association Journal found that patients using PPIs for continued use (5 to 7 years or more) are at an increased risk of developing hip, spinal or wrist fractures. According to the study, patients at the most risk include those of 50 years of age or older.

Individuals who are currently prescribed to any of the http://proton-pump-inhibitors-ppi.legalview.com [proton pump inhibitors __title__ Proton Pump Inhibitor Lawsuit] such as pantoprazole, rabeprazole, esomeprazole, lansoprazole and omeprazole are encouraged to contact an experienced pharmaceutical lawyer to better understand how to develop a potential http://proton-pump-inhibitors-ppi.legalview.com [PPI __title__ Proton Pump Inhibitor Lawsuit] lawsuit. Several of the PPIs are more commonly known under their brand names including Losec, Prilosec, Inhibitol, Somac, Protonix, Pantoloc, Rabecid and Aciphex.

PPIs are used to inhibit gastric secretion entering the stomach. A pump within the stomach that funnels gastric acids is stopped when taking PPIs. These drugs treat an array of conditions including peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), prevention of stress gastritis, gastrinomas, dyspepsia, etc. However, the drugs may also stop the absorption of calcium while stopping the secretion of gastric acids thus causing bone fractures. The http://proton-pump-inhibitors-ppi.legalview.com [PPI side effects __title__ PPI Side Effects] also includes headache, nausea, diarrhea, dizziness, abdominal pain, dizziness and fatigue. To learn more about how proton pump inhibitors work and who is at risk for the drug's side effects, visit http://proton-pump-inhibitors-ppi.legalview.com/.

LegalView also offers details on other legal topics and offers readers a library of information portals relating to several controversial pharmaceutical drugs/products such as Avandia, Ketek and the Zimmer Durom cups.

Avandia is a type 2 diabetes drug that has continued to find its way into news headlines over the drug's side effects. Several studies have concluded that the http://avandia.legalview.com [Avandia risks __title__ Avandia Dangers] may cause serious complications for patients. The drug has been linked to early on-set osteoporosis, increased risk of bone fracture, heart failure and unstable angina. The U.S. Food and Drug Administration (FDA) has yet to issue a recall or increase the drug's warnings, but individuals who show any signs or symptoms of the drug's risk should seek medical attention immediately.

Since 2004, Ketek has been prescribed to patients suffering from upper respiratory infections. The antibiotic from Sanofi-Aventis was recently under fire as reports of the drug's adverse effects began to surface. The FDA has been investigating accounts of liver disease and liver failure developing among Ketek patients. Additionally, patients of the antibiotic showing any signs of the http://ketek.legalview.com [Ketek side effects __title__ Ketek Class Action], which include yellowing or jaundice of the skin, are advised to discontinue use of the drug and consult a physician.

The Durom cup is an artificial hip socket component used in hip replacement surgeries. The company manufacturing the cup, Zimmer Holdings, has been selling the hip component since 2006. Within that time, the artificial hip socket has had nearly 12,000 Durom cups surgically implanted into patients across the country. However, physicians recently began to complain that the hip socket was failing in many patients. Since reports of the http://zimmer-durom-cup.legalview.com [Zimmer Durom cup failure __title__ Zimmer Durom Cup Recall] have began the company has halted production of additional Durom cups, however, no recall has been issued.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1300514.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
2. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
5. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
6. Humanitarian Needs From Georgia Conflict Still Growing, World Vision Warns
7. Lap-Band "Tell-All" Warns of Patients Becoming Lap-Band "Orphans"
8. New report warns current policies will not avert health workforce crisis
9. Climate change may challenge national security, classified report warns
10. PA Agriculture Department Warns Consumers About Raw Milk Sold by York County Dairy
11. FDA Warns Companies to Stop Selling Fake Cancer Cures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, ... of few medical professionals in the country to sit on the 2017 National Advisory ... in just 2 years Dr. Harper helped propel the clinic from a small start-up ...
(Date:3/28/2017)... ... 28, 2017 , ... AutismOne announced the Board Certified in ... Medicine and available for application on Saturday, May 27, 2017, following Thursday, Friday, ... Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities termed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of ... opened in Marshallville in 2006, and a bagging and shipping facility has been in ... Patten Seed operations to the Middle Georgia location from their previous home in Lakeland, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... The global surgical sealants ... of USD 4.5 billion by 2025, according to a ... of injured tissues post operation is a major step ... in 3% to 15% of cases and are considered ... third of postoperative deaths in patients. Surgical sealants and ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Bayer and its partnering interests and activities since ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ... data. The report will be delivered in PDF ...
(Date:3/27/2017)...  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the ... of common stock in an underwritten public offering under ... Securities and Exchange Commission (the "SEC"). The offering is ... be no assurance as to whether or when the ... size or terms of the offering. Cryoport also expects ...
Breaking Medicine Technology: